IL17A and type 2 diabetes mellitus: Paradoxically, clinical studies report significantly lower serum IL-17A levels in T2DM patients compared to normoglycemic controls (73), indicating a potential dissociation between local tissue inflammation and systemic immune responses, reflecting compartmentalized inflammation.